LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 69.32 | 771.67 | 10006 | 10212 | 0.9798 | 0.9891 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 71.54 | 771.67 | 10306 | 10532 | 0.9785 | 0.9885 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 71.54 | 771.67 | 10288 | 10532 | 0.9768 | 0.9876 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 73.76 | 771.67 | 10365 | 10851 | 0.9552 | 0.9761 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 73.76 | 771.67 | 10516 | 10851 | 0.9691 | 0.9836 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 76.02 | 771.67 | 10483 | 11106 | 0.9438 | 0.9702 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 76.02 | 771.67 | 10653 | 11106 | 0.9592 | 0.9784 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 78.25 | 771.67 | 10507 | 11367 | 0.9243 | 0.9598 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 78.25 | 771.67 | 10919 | 11367 | 0.9605 | 0.9794 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 80.48 | 771.67 | 10621 | 11685 | 0.9089 | 0.9519 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 80.48 | 771.67 | 11170 | 11685 | 0.9559 | 0.9771 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 82.69 | 771.67 | 10587 | 11974 | 0.8842 | 0.9387 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 82.69 | 771.67 | 11350 | 11974 | 0.9479 | 0.9731 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 84.92 | 771.67 | 10619 | 12266 | 0.8657 | 0.9290 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 84.92 | 771.67 | 11572 | 12266 | 0.9434 | 0.9710 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 87.14 | 771.67 | 10567 | 12592 | 0.8392 | 0.9148 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 87.14 | 771.67 | 11796 | 12592 | 0.9368 | 0.9678 | MN20160304_L01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.49 | 771.67 | 904 | 867 | 1.0418 | 1.5469 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.49 | 771.67 | 742 | 867 | 0.8551 | -0.2067 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.71 | 771.67 | 1016 | 956 | 1.0623 | 1.4315 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.71 | 771.67 | 808 | 956 | 0.8449 | 0.1602 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.94 | 771.67 | 1119 | 1045 | 1.0707 | 1.3378 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.94 | 771.67 | 897 | 1045 | 0.8583 | 0.4105 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 9.16 | 771.67 | 1203 | 1138 | 1.0567 | 1.2064 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 9.16 | 771.67 | 952 | 1138 | 0.8362 | 0.4540 | MN20160304_L01 | G18 |